MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ZIOPHARM Oncology Company Profile (NASDAQ:ZIOP)

Consensus Ratings for ZIOPHARM Oncology (NASDAQ:ZIOP) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $11.50 (106.09% upside)

Analysts' Ratings History for ZIOPHARM Oncology (NASDAQ:ZIOP)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Wells FargoReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Griffin SecuritiesReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016Raymond JamesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016MizuhoBoost Price TargetNeutral$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$15.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for ZIOPHARM Oncology (NASDAQ:ZIOP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q1($0.08)($0.09)$1.89 million$1.97 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q4($0.07)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q315($0.13)($0.14)$1.19 million$1.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q2($0.22)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015($0.13)($0.10)$0.20 million$0.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.14)($0.09)$420.00 million$0.34 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.12)($0.06)$3.43 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.17)($0.06)$7.50 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.10)($0.10)$0.20 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413($0.15)($0.09)$0.20 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313($0.17)($0.20)$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.24)($0.22)$0.20 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/18/2013Q4 2012($0.29)($0.48)$0.17 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.28)($0.28)$0.20 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012($0.23)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012($0.22)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2012($0.23)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.28)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2011($0.23)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for ZIOPHARM Oncology (NASDAQ:ZIOP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)
Dividend History for ZIOPHARM Oncology (NASDAQ:ZIOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for ZIOPHARM Oncology (NASDAQ:ZIOP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/4/2015Murray BrennanDirectorSell40,000$9.70$388,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Randal J KirkDirectorBuy1,440,000$8.75$12,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Randal J KirkDirectorBuy2,857,143$3.50$10,000,000.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for ZIOPHARM Oncology (NASDAQ:ZIOP)
DateHeadline
06/28/16 07:23 PMStocks Active on Selling Boundary- ZIOPHARM Oncology (NASDAQ:ZIOP), Zynerba Pharmaceuticals (NASDAQ:ZYNE ... - Seneca Globe
06/28/16 07:23 PMUpdated Analysts Rating Report: Bristol-Myers Squibb Company (NYSE:BMY) , ZIOPHARM Oncology Inc (NASDAQ ... - Street Updates
06/28/16 04:17 AMZiopharm Oncology (ZIOP) Completes Enrollment in Second Patient Cohort of Phase 1 Study of Ad-RTS-hIL-12
06/27/16 07:10 PMZIOPHARM ONCOLOGY INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
06/24/16 07:24 PMPrice Target Update on ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Trade Calls
06/23/16 09:56 AMZIOPHARM Oncology Inc (NASDAQ:ZIOP) Analyst Rating Consensus - Trade Calls
06/20/16 08:45 AMThis Weeks Broker Views For ZIOPHARM Oncology Inc (ZIOP) - Fiscal Standard
06/18/16 06:20 PMBetter Buy: Ziopharm Oncology, Inc. vs. Celgene - Motley Fool
06/18/16 04:20 AMCan ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Meet Analysts Expectations? - Stocks Daily
06/17/16 07:08 PMZIOPHARM ONCOLOGY INC : Submission of Matters to a Vote of Security Holders (form 8-K)
06/17/16 10:07 AMStocks within investor Spotlight: ZIOPHARM Oncology Inc (NASDAQ:ZIOP) , Geron Corporation (NASDAQ:GERN) - Street Updates
06/15/16 07:16 PMHC Stocks Highlights: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Galena Biopharma Inc (NASDAQ:GALE) - share market updates (press release)
06/15/16 07:16 PMHot Stock seeking Investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - News Oracle
06/15/16 03:59 PMZIOPHARM ONCOLOGY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/14/16 04:12 AMAnalyst Recommendations on These Hot Stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Dominion Resources, Inc ... - Beacon Chronicle
06/13/16 10:21 AMHC Stocks Impression: Celldex Therapeutics, Inc. (NASDAQ:CLDX), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - share market updates (press release)
06/13/16 10:21 AMOverview of Analyst's Recommendations: Amicus Therapeutics, Inc. (NASDAQ:FOLD) , ZIOPHARM Oncology Inc ... - Street Updates
06/11/16 10:21 AMZIOPHARM Oncology Inc (ZIOP) Drops 5.34% on June 09 - Equities.com
06/10/16 07:53 PMTake a look at Price Moves: ZIOPHARM Oncology Inc (NASDAQ:ZIOP) , Quest Diagnostics Incorporated (NYSE:DGX) - Street Updates
06/10/16 10:34 AMAnalyst Overview on These Stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Zoetis Inc. (NYSE:ZTS) - Beacon Chronicle
06/09/16 12:58 PMZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/09/16 10:35 AMEarnings Report of the Stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Danaher Corp. (NYSE:DHR) - Beacon Chronicle
06/08/16 08:03 PMEarnings Report of the Stocks: Danaher Corp. (NYSE:DHR), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - Beacon Chronicle
06/08/16 08:03 PMZIOPHARM ONCOLOGY INC. (NASDAQ:ZIOP) Financial Condition Compared to S&P 500 - CML News
06/07/16 10:23 AMAnalysts Rating Overview: Oncothyreon Inc. (NASDAQ:ONTY) , ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Street Updates
06/07/16 10:23 AMEarnings Trends of the Stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Community Health Systems, Inc. (NYSE:CYH) - Beacon Chronicle
06/06/16 04:48 PMETF’s with exposure to ZIOPHARM Oncology, Inc. : June 6, 2016 -
06/04/16 07:31 PMWere Analysts Bullish ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) This Week? - HNN
06/03/16 10:34 AMHologic, Inc. (NASDAQ:HOLX) & ZIOPHARM Oncology (NASDAQ:ZIOP) are Hot Healthcare Stocks - Wall Street 24
06/03/16 10:34 AMHealthcare Intraday Movers: Agenus Inc (NASDAQ:AGEN), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - NYSE Journal (press release)
06/03/16 10:34 AMStock Earnings Report: General Dynamics Corporation (NYSE:GD), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - Beacon Chronicle
06/02/16 08:02 PMZIOPHARM Oncology Inc (NASDAQ:ZIOP) Quarterly EPS Estimate At $-0.110 - Investor Newswire - ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Quarterly EPS Estimate At $-0.110Investor NewswireFirst Call stated that ZIOPHARM Oncology Inc (NASDAQ:ZIOP) can touch $14.000 in coming one year. For the next quarter, the per-share earnings target is $-0.110 and for ongoing fiscal at $-0.430. EPS target for next year is $-0.450 versus the mean EPS ...and more »
06/02/16 10:49 AMAnalysts Rating Alert: Johnson & Johnson (NYSE:JNJ) , ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Street Updates - Analysts Rating Alert: Johnson & Johnson (NYSE:JNJ) , ZIOPHARM Oncology Inc (NASDAQ:ZIOP)Street UpdatesZIOPHARM Oncology Inc (NASDAQ:ZIOP) showed bearish move with loss of -0.64% after exchanging volume of 1.58 million shares in last trading session ended on 6/1/2016. The company recent traded volume was lower than its average volume of 2.55 ...and more »
06/01/16 08:13 PMCerecor Inc. (NASDAQ:CERC) fell down -6.02%: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Astoria Financial ... - KC Register - Cerecor Inc. (NASDAQ:CERC) fell down -6.02%: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Astoria Financial ...KC RegisterZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced that interim results from the Company's ongoing Phase 1, multi-center dose-escalation study of the gene therapy candidate Ad-RTS-hIL-12 + orally-administered veledimex in patients with recurrent or ...
06/01/16 08:13 PMMovers to Watch: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Minerva ... - The Point Review - The Point ReviewMovers to Watch: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Minerva ...The Point ReviewShares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) fell -1.80% to $7.65 at 11:35 AM EDT. The stock attained the volume of 531,902 shares recently versus average trading volume of 2.56 Million shares. If we take a look on its volatility, 5.14 percent was ...Analyst Coverage: ZIOPHARM Oncology Inc (ZIOP)Risers & FallersActive Biotech Stock News: ZIOPHARM Oncology, Inc. (ZIOP), Portola Pharmaceuticals, Inc. (PTLA)ZergwatchAnalyst Revenue Highlights: Celator Pharmaceuticals Inc. (NASDAQ:CPXX), ZIOPHARM Oncology Inc (NASDAQ:ZIOP)WsNews 4investorsLet Me Know About This -CWRU Observer -share market updates (press release)all 10 news articles »
06/01/16 10:32 AMStock Review and Earnings Check on ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - HNN - Stock Review and Earnings Check on ZIOPHARM Oncology Inc (NASDAQ:ZIOP)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting ZIOPHARM Oncology Inc ...and more »
05/31/16 07:53 PMZIOPHARM Oncology Inc (ZIOP) Jumps 5.41% on May 31 - Equities.com - ZIOPHARM Oncology Inc (ZIOP) Jumps 5.41% on May 31Equities.comZIOPHARM Oncology Inc (ZIOP) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 5.41% to $7.79, representing a gain of $0.4 per share. Some 2.53 million shares traded hands on 10,119 trades, compared with an ...and more »
05/31/16 10:08 AMEarnings Expectations Overview: Agilent Technologies (A), ZIOPHARM Oncology (ZIOP) - Beacon Chronicle - Beacon ChronicleEarnings Expectations Overview: Agilent Technologies (A), ZIOPHARM Oncology (ZIOP)Beacon ChronicleZIOPHARM Oncology Inc. (NASDAQ:ZIOP) currently has High Price Target of $21.00. The Low and Mean Price Targets are $7.00 and $14.00 respectively. These price targets are a consensus analysis of 2 brokers. When having a look at Recommendation ...and more »
05/30/16 10:34 PMEarnings Stock Analysis: NovaGold Resources Inc. (USA) (NYSEMKT:NG), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - News Oracle - Earnings Stock Analysis: NovaGold Resources Inc. (USA) (NYSEMKT:NG), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)News OracleThe stock declined-4.67% and closed its last session at $5.10. The Company has the market capitalization of 1.64 Billion. The 52-Week Range ranges between $2.65 and $6.57. The stock traded with the Volume of 2.26 Million in the last trading day whereas ...and more »
05/27/16 09:17 AMInvestor's Healthcare Focused Stocks: Celgene Corporation (NASDAQ:CELG) , ZIOPHARM Oncology Inc (NASDAQ ... - Is stories - Investor's Healthcare Focused Stocks: Celgene Corporation (NASDAQ:CELG) , ZIOPHARM Oncology Inc (NASDAQ ...Is storiesIn most recently trading session on 5/26/2016, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) dropped -0.56% while traded on 1.41 million shares versus it's an average volume of 2.61 million shares. The company recorded the last trade with the price of $7.06.and more »
05/26/16 11:16 PMGriffin Reiterates Buy on ZIOPHARM Oncology Inc. (ZIOP) Following Encouraging Data From IL-12 Trial - Smarter Analyst - Smarter AnalystGriffin Reiterates Buy on ZIOPHARM Oncology Inc. (ZIOP) Following Encouraging Data From IL-12 TrialSmarter AnalystGriffin's healthcare analyst Keith Markey weighed in on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), after the oncology biotech firm disclosed interim Phase 1 data for IL12 gene therapy product Ad-RTS-hIL12, in patients suffering from relapsed/refractory ...Active Biotech Stock News: ZIOPHARM Oncology (ZIOP), Arena Pharmaceuticals (ARNA)ZergwatchHealthcare Moving Stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Gilead Sciences, Inc. (NASDAQ:GILD)Is storiesZIOPHARM Oncology Inc (ZIOP) Updated Broker Price TargetsShare Trading NewsWall Street Hints and News -iStreetWireall 6 news articles »
05/26/16 06:06 PMHealthcare Moving Stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Gilead Sciences, Inc. (NASDAQ:GILD) - Is stories - Wall Street JournalHealthcare Moving Stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Gilead Sciences, Inc. (NASDAQ:GILD)Is storiesGilead Sciences, Inc. (NASDAQ:GILD) increased +0.34% to $86.51 while traded 11.65 million shares on 5/25/2016. The stock price negotiated for value between $85.70 to $87.00 in recent trading session. During the past 52 weeks, the stock's price ...Market Analyst's Checklist Stocks: Gilead Sciences, Inc. (NASDAQ:GILD), ZIOPHARM Oncology Inc (NASDAQ:ZIOP)WsNews 4investorsall 95 news articles »
05/25/16 09:21 AMHC Stocks Impression: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Opko Health Inc. (NYSE:OPK) - share market updates (press release) - share market updates (press release)HC Stocks Impression: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Opko Health Inc. (NYSE:OPK)share market updates (press release)Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ended Tuesday session in green amid volatile trading. The shares closed up +0.06 points or 0.86% at $7.02 with 2.27 million shares getting traded. Post opening the session at $7.02, the shares hit an ...
05/23/16 11:02 AMEarnings Overview of the Stock: St. Jude Medical, Inc. (NYSE:STJ), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - Beacon Chronicle - Beacon ChronicleEarnings Overview of the Stock: St. Jude Medical, Inc. (NYSE:STJ), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)Beacon ChronicleZIOPHARM Oncology Inc. (NASDAQ:ZIOP) currently has High Price Target of $7.00. The Low and Mean Price Targets are $7.00and $7.00respectively. These price targets are a consensus analysis of 1 brokers. When having a look at Recommendation ...and more »
05/22/16 10:34 PMAfter Last Week What Do Analysts Think Of ZIOPHARM Oncology Inc (ZIOP) - Share Trading News - After Last Week What Do Analysts Think Of ZIOPHARM Oncology Inc (ZIOP)Share Trading News01/14/2016 – ZIOPHARM Oncology Inc had its “neutral” rating reiterated by analysts at JP Morgan. 12/10/2015 – Griffin Securities began new coverage on ZIOPHARM Oncology Inc giving the company a “buy” rating. They now have a USD 21 price target on ...
05/22/16 10:41 AMOcean Rig UDW Inc, Sarepta Therapeutics Inc, Ziopharm Oncology Inc., Ross Stores, Inc: Pre-Market Movers Today - Bidness Etc discusses the major pre-market movers today. These include Ocean Rig UDW and Sarepta Therapeutics stocks, which are up over 45% and 5%, respectively. On the other hand Ziopharm Oncology and Ross Stores stocks respectively fell nearly 5% and 6.5%.
05/21/16 09:26 AMWells Fargo Maintains Underperform On ZIOPHARM Oncology Inc. (ZIOP) Following Review Of ASCO Abstract Data - Smarter Analyst - Wells Fargo Maintains Underperform On ZIOPHARM Oncology Inc. (ZIOP) Following Review Of ASCO Abstract DataSmarter AnalystWells Fargo analyst Jim Birchenough maintained an Underperform rating on shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), with a valuation range of $5.00 to $8.00, after the company released interim phase 1 data for its IL12 gene therapy product ...Analyst Review Alert: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)CWRU ObserverTop Biotechnology Stock Picking: ZIOPHARM Oncology, Inc. (ZIOP), PTC Therapeutics, Inc. (PTCT)ZergwatchZIOPHARM Oncology Said to be in 'Own Mini Biotech Bubble': TheStreet (NASDAQ:ZIOP)Sonoran Weekly ReviewShare Trading News -Trade Calls -Street Registerall 7 news articles »
05/20/16 05:57 PMOcean Rig UDW Inc, Sarepta Therapeutics Inc, Ziopharm Oncology Inc., Ross Stores, Inc: Pre-Market Movers Today - Bidness ETC - Bidness ETCOcean Rig UDW Inc, Sarepta Therapeutics Inc, Ziopharm Oncology Inc., Ross Stores, Inc: Pre-Market Movers TodayBidness ETCBidness Etc discusses the major pre-market movers today. These include Ocean Rig UDW and Sarepta Therapeutics stocks, which are up over 45% and 5%, respectively. On the other hand Ziopharm Oncology and Ross Stores stocks respectively fell nearly ...and more »
05/20/16 09:40 AMMost Recent Stocks Movements: Bristol-Myers Squibb Company (NYSE:BMY) , ZIOPHARM Oncology Inc (NASDAQ ... - Street Updates - Most Recent Stocks Movements: Bristol-Myers Squibb Company (NYSE:BMY) , ZIOPHARM Oncology Inc (NASDAQ ...Street UpdatesIn the past trading session, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) highlighted downward shift of -1.86% or -0.13 points to $6.87. The company traded a volume of 2.97 million shares over average volume of 2.68 million shares. Trailing twelve month period ...and more »
05/20/16 06:00 AMZiopharm Subpar Cancer Therapies Can't Support Lofty Market Valuation -
About ZIOPHARM Oncology

ZIOPHARM Oncology logoZIOPHARM Oncology, Inc. is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. Its clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. The Company's Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. It has initiated the Phase I study for malignant glioma. The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. It has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer. Its initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ZIOP
  • CUSIP: 98973P10
Key Metrics:
  • Previous Close: $5.58
  • 50 Day Moving Average: $6.82
  • 200 Day Moving Average: $7.22
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $726.61M
  • Current Quarter EPS Consensus Estimate: $-0.43 EPS
Additional Links:
ZIOPHARM Oncology (NASDAQ:ZIOP) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha